medicine department News
-
World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board
MENLO PARK, Calif., January 8, 2018 – NuMedii, Inc. today announced the formation of an Idiopathic Pulmonary Fibrosis (IPF) Advisory Board consisting of the world’s leading experts in interstitial lung disease: Naftali Kaminski, MD; David A. Schwartz, MD; Kevin Brown, MD; Toby Maher, MD, PhD; Gisli Jenkins, MD, PhD; Zea Borok, MD; and, Paul Wolters, MD. The newly formed Board of ...
-
Economic Considerations in the Management of Heart Failure Explored on New Episode of the Heart Failure Beat Podcast
Tune into this episode of HF Beat to hear our co-hosts interview Paul Heidenreich, MD, FHFSA, a co-author of the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure about economic considerations in the management of HF. On "From Failure to Function", Priya dives into the late breaking trials from ACC.23 and Michael reviews three papers on HFpEF on HF Rounds. ...
-
Agilent Technologies expands next-generation sequencing target-enrichment platform with SureCall Software upgrade
Agilent Technologies Inc. (NYSE: A) today introduced SureCall version 2.0 software, expanding the capabilities of the company's current market-leading, next-generation sequencing target-enrichment solutions. The newly upgraded software features compatibility with SureSelect custom target-enrichment and Human All Exon panels. One of the biggest challenges faced by clinical research labs when ...
-
Aatru Medical Abstract Accepted for Presentation in Two Leading 2020 Wound Healing Conferences
Aatru Medical, LLC ("Aatru") announced today that its technical Abstract has been accepted for presentation at both the SAWC/WHS 2020 conference in North Carolina and also at EWMA 2020, to be held in London, England. The 2020 Symposium on Advanced Wound Care (SAWC)/Wound Healing Society (WHS) meeting is the largest gathering of wound care professionals in the US. The European Wound Management ...
-
Smiths Detection announces University of Maryland, Baltimore County successfully deploys BioFlash for airborne detection of SARS-CoV-2
Smiths Detection, a global leader in threat detection and security screening technologies, today announces that its BioFlash Biological Identifier has been successfully used by the University of Maryland, Baltimore County (UMBC) to identify airborne SARS-CoV-2 inside their campus in real-time at the point of testing. As part of their mitigation strategy for COVID-19, UMBC’s Environmental ...
-
Dr. John Peabody Delivers 2021 Rocky Vista University (RVU) Commencement Speech
Rocky Vista University (RVU) celebrated the graduation of 154 medical students from its College of Osteopathic Medicine (COM) and 37 graduate students from its Master of Science in Biomedical Sciences (MSBS) program on the Colorado campus. RVU hosted the small-scale commencement ceremony for students and their guests in the University’s auditoriums with masks and distanced ...
-
Collaboration with the Nuffield Department of Medicine, University of Oxford will use recombinant overlapping peptide technology to develop a novel vaccine and diagnostic tests for Covid-19
Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focusing on the development of cancer vaccines, announced today that it will use its proprietary recombinant overlapping peptide (ROP) technology to develop a new vaccine and diagnostic tests for Covid-19. The research will be carried out in collaboration with the renowned Nuffield Department of Medicine (NDM) at the University of ...
-
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress on June 25, 2022
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Stephen A. Harrison, Medical Director, Pinnacle Clinical Research, will present the results of Altimmune’s recently completed Phase 1, first-in-human clinical trial of pemvidutide in an oral presentation at the European Association for the Study of the Liver (EASL) International Liver ...
-
Daxor Corporation Awarded Grant from the Center for Advancing Point of Care Technologies (Capcat) to Develop a Point-Of-Care Blood Volume Analyzer
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from the Center for Advancing Point of Care Technologies (CAPCaT), a program run by the Massachusetts Medical Device Development Center (M2D2) funded by the National Heart, Lung, and Blood Institute and the National Center for Complementary and Integrative ...
-
Lakhmir Chawla, MD, of Silver Creek Pharmaceuticals Joins ExThera Medical Board of Directors
Professor Lakhmir Chawla, MD, has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company whose Seraph 100 Microbind Affinity Blood Filter is authorized in the United States to treat critically ill COVID-19 patients. Dr. Chawla also serves as the Chair of the Scientific Advisory Board at the company Dr. Chawla is an internationally renowned ...
-
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the Zephyr® Endobronchial Valve for treating severe COPD/emphysema patients following a positive recommendation by Pharmaceuticals and Medical Devices Agency (PMDA). ...
-
Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss
Expansion of Pipeline Into a Third Neuronal Cell Type Builds on Existing Capabilities Intellectual Property Has Been Filed Covering Composition and Methods for Generating Auditory Neuronal Progenitors Hearing Loss Afflicts More Than 5% of the Population; More Than 430 Million People Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company ...
-
The Newly Developed Metabolomics Platform Brings New Insights into Enteroaggregative E. coli
With years of experience in metabolomics services, Creative Proteomics has developed a microbial metabolome analysis platform dedicated to providing high-quality, personalized microbial metabolomics services and reliable data support to clients worldwide. Microorganisms have existed on Earth for at least 3.8 billion years and are found in almost all corners of the biosphere. The diversity of ...
-
TVAX Biomedical Secures $2 Million Financing Round for Animal Health Subsidiary
TVAX Biomedical Inc., a clinical stage development company advancing novel targeted T cell based immunotherapy for the treatment of cancer, today announced it has closed a $2 million financing round for its animal health subsidiary. The financing was led by two private investors and included MidAmerica Angels, an angel investor network focused on early-stage, high-growth companies in Kansas and ...
-
Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology
Thermo Fisher Scientific today announced that submissions are now open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology. This grant aims to provide funding for high-quality molecular profiling studies focusing on the impact of immune-based treatments for cancer patients. Through the Oncomine Clinical Research Grant program, Thermo Fisher will ...
-
Thermo Fisher Scientific Supports Sepsis Awareness Month in September
Thermo Fisher Scientific Inc., the world leader in serving science, announces its support of Sepsis Awareness Month to drive awareness around sepsis, a complex clinical syndrome and a leading cause of death globally.1 Throughout the month of September, supporters are encouraged to join together to raise sepsis awareness through posting on social media, handing out brochures or stickers, giving ...
-
NuMedii Announces Creation of World’s First Single-Cell Sequencing Atlas for Idiopathic Pulmonary Fibrosis by its Collaborators
SAN MATEO, Calif., July 9, 2020 /PRNewswire/ — NuMedii, Inc., a data-driven drug discovery company, today announced the availability of the world’s first single-cell sequencing atlas for idiopathic pulmonary fibrosis (IPF) that was the result of a strategic research collaboration including the Yale School of Medicine, Baylor College of Medicine, Brigham and Women’s Hospital, and ...
-
Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
ESR1 mutations are present in up to 40% of ER+, HER2- advanced or metastatic breast cancers. ESR1 mutations are a known driver of resistance to standard endocrine therapy, and so far, have been difficult to treat. ORSERDU is the first endocrine innovation in more than 20 years, specifically addressing ESR1 mutations, a major unmet need. The Menarini Group (“Menarini”), a ...
-
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis
Longest available outcomes data with LUPKYNIS will be presented virtually during American College of Rheumatology (ACR) Convergence 2021; final results expected by the end of 2021 – Updated interim analysis shows sustained safety and tolerability of LUPKYNIS compared with placebo - Individuals treated with LUPKYNIS sustained meaningful reductions in proteinuria with stable eGFR at 30 ...
-
Building comprehensive breast cancer care eco-system for the wellness of cancer patients and their families by joint efforts of Beijing Love Book Cancer Foundation (LBCF) and Aurora
Beijing Love Book Cancer Foundation and Aurora Healthcare US Corp are pleased to announce their partnership to build a comprehensive breast cancer care eco-system for the wellness of women, breast cancer patients and their families. High morbidity and mortality of breast cancer in China have become one of the major healthcare and social problems, with more than 360,000 newly diagnosed cases ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you